Log In
Print this Print this

Ovcon 35

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionOral contraceptive, combination of norethindrone and ethinyl estradiol
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationContraception
Indication DetailsPrevent pregnancy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today